Skip to content

Septerna, Inc. SEPN Other Income (Expense)

Other Income (Expense) at other companies

Amgen logo
AmgenAMGN
$75M-95.1%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.42M+17.1%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$4.36M+43.1%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$500K
Precigen logo
PrecigenPGEN
-$1.94M+93.9%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$11M+38.9%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.65B+319%
Enterprise value$1.6B+1,325%
P/S22.8×-379×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s other income (expense)?
Septerna, Inc. (SEPN) reported other income (expense) of $5M in Q1 2026.
How has Septerna, Inc.'s other income (expense) changed year-over-year?
Septerna, Inc.'s other income (expense) increased by 12.8% year-over-year, from $4.43M to $5M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.